Epstein–Barr virus and multiple sclerosis
SS Soldan, PM Lieberman - Nature Reviews Microbiology, 2023 - nature.com
Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-
established causal role in several cancers. Recent studies have provided compelling …
established causal role in several cancers. Recent studies have provided compelling …
Primary epstein-barr virus infection
SK Dunmire, PS Verghese, HH Balfour Jr - Journal of Clinical Virology, 2018 - Elsevier
Epstein-Barr virus (EBV) infects about 90% of adults worldwide. It is the main cause of
infectious mononucleosis, which is observed most frequently in adolescents. The disease …
infectious mononucleosis, which is observed most frequently in adolescents. The disease …
Herpesviruses: latency and reactivation–viral strategies and host response
B Grinde - Journal of oral microbiology, 2013 - Taylor & Francis
Eight members of the Herpesviridae family commonly infect humans, and close to 100% of
the adult population is infected with at least one of these. The five that cause the most health …
the adult population is infected with at least one of these. The five that cause the most health …
Progress and problems in understanding and managing primary Epstein-Barr virus infections
OA Odumade, KA Hogquist… - Clinical microbiology …, 2011 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
[HTML][HTML] Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site
M Kanekiyo, W Bu, MG Joyce, G Meng, JRR Whittle… - Cell, 2015 - cell.com
Epstein-Barr virus (EBV) represents a major global health problem. Though it is associated
with infectious mononucleosis and∼ 200,000 cancers annually worldwide, a vaccine is not …
with infectious mononucleosis and∼ 200,000 cancers annually worldwide, a vaccine is not …
Epstein-Barr virus: an important vaccine target for cancer prevention
JI Cohen, AS Fauci, H Varmus, GJ Nabel - Science translational …, 2011 - science.org
Participants at the February 2011 meeting at the US National Institutes of Health on Epstein-
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals …
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals …
[HTML][HTML] Epstein–Barr virus infection and posttransplant lymphoproliferative disorder
M Green, MG Michaels - American Journal of Transplantation, 2013 - Elsevier
Epstein–Barr virus (EBV) is an important pathogen in recipients of solid organ transplants
(SOT). Infection with EBV manifests as a spectrum of diseases/malignancies ranging from …
(SOT). Infection with EBV manifests as a spectrum of diseases/malignancies ranging from …
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Abstract Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus,
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
W Li, X Duan, X Chen, M Zhan, H Peng… - Frontiers in …, 2023 - frontiersin.org
Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …
Epstein–barr virus vaccines
JI Cohen - Clinical & translational immunology, 2015 - Wiley Online Library
Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis (IM) and is
associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric …
associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric …